Revenue | ₹1,758.54Cr |
Net Profits | ₹261.48Cr |
Net Profit Margins | 14.87% |
Gland Pharma Ltd’s revenue jumped 21.9% since last year same period to ₹1,758.54Cr in the Q3 2025-2026. On a quarterly growth basis, Gland Pharma Ltd has generated 11.93% jump in its revenue since last 3-months.
Gland Pharma Ltd’s net profit jumped 27.74% since last year same period to ₹261.48Cr in the Q3 2025-2026. On a quarterly growth basis, Gland Pharma Ltd has generated 42.36% jump in its net profits since last 3-months.
Gland Pharma Ltd’s net profit margin jumped 4.79% since last year same period to 14.87% in the Q3 2025-2026. On a quarterly growth basis, Gland Pharma Ltd has generated 27.18% jumped in its net profit margins since last 3-months.
The revenue for Gland Pharma Ltd in the Q3 results 2025 was ₹1,758.54Cr.
The net profit for Gland Pharma Ltd in the Q3 results 2025 was ₹261.48Cr.
The net profit margin for Gland Pharma Ltd in the Q3 results 2025 was 14.87%.
The revenue for Gland Pharma Ltd in the Q3 results 2024 was ₹1,442.55Cr.
The net profit for Gland Pharma Ltd in the Q3 results 2024 was ₹204.69Cr.
The net profit margin for Gland Pharma Ltd in the Q3 results 2024 was 14.19%.